1. Revisiting FDA approval of Aducanumab;Alexander;N. Engl. J. Med.,2021
2. Controversy and Progress in Alzheimer’s disease - FDA approval of Aducanumab;Rabinovici;N. Engl. J. Med.,2021
3. Cleveland Clinic, Mount Sinai and Providence Won’t Give Biogen’s New Alzheimer’s drug;Walker;Wall Street J.,2021
4. Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease. Proposed National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s DiseasePress;Baldwin,2022
5. Approval of Aducanumab for Alzheimer Disease-The FDA’s perspective;Dunn;JAMA Intern. Med.,2021